Engineered kinases as a tool for phosphorylation of selected targets in vivo

Author:

Lepeta Katarzyna1ORCID,Roubinet Chantal2ORCID,Bauer Milena1,Vigano M. Alessandra1ORCID,Aguilar Gustavo1ORCID,Kanca Oguz3,Ochoa-Espinosa Amanda4ORCID,Bieli Dimitri5,Cabernard Clemens6ORCID,Caussinus Emmanuel7,Affolter Markus1ORCID

Affiliation:

1. Biozentrum, University of Basel, Basel, Switzerland 1

2. MRC Laboratory for Molecular Cell Biology, University College London, London, UK 2

3. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 3

4. Department of Biomedicine, University of Basel, Basel, Switzerland 4

5. Mabylon AG, Schlieren, Switzerland 5

6. Department of Biology, University of Washington, Seattle, WA 6

7. 1 Avenue Georges Ferrenbach, Kaysersberg-Vignoble, France 7

Abstract

Reversible protein phosphorylation by kinases controls a plethora of processes essential for the proper development and homeostasis of multicellular organisms. One main obstacle in studying the role of a defined kinase–substrate interaction is that kinases form complex signaling networks and most often phosphorylate multiple substrates involved in various cellular processes. In recent years, several new approaches have been developed to control the activity of a given kinase. However, most of them fail to regulate a single protein target, likely hiding the effect of a unique kinase–substrate interaction by pleiotropic effects. To overcome this limitation, we have created protein binder-based engineered kinases that permit a direct, robust, and tissue-specific phosphorylation of fluorescent fusion proteins in vivo. We show the detailed characterization of two engineered kinases based on Rho-associated protein kinase (ROCK) and Src. Expression of synthetic kinases in the developing fly embryo resulted in phosphorylation of their respective GFP-fusion targets, providing for the first time a means to direct the phosphorylation to a chosen and tagged target in vivo. We presume that after careful optimization, the novel approach we describe here can be adapted to other kinases and targets in various eukaryotic genetic systems to regulate specific downstream effectors.

Funder

Swiss National Science Foundation

National Institutes of Health

Publisher

Rockefeller University Press

Subject

Cell Biology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3